News | August 06, 2007

Patients Get ECG to Test BNP’s Effectiveness

August 7, 2007 – After using a portable echocardiography to test the potential of B-type natriuretic peptide (BNP) assay in diagnosing heart failure among patients registered as having heart failure in a single primary care practice, researchers determined that BNP level is not useful for validating a primary care register diagnosis of heart failure, according to a report in the July 30th BMC Cardiovascular Disorders.

"This study was designed to see if BNP testing would be of use in validation," said lead researcher, Russell C. Davis, M.D., Sandwell & West Birmingham Hospitals NHS Trust, West Bromwich, UK.

In the study, just 70 of 112 patients with a record of previous heart failure investigations had echocardiography reports consistent with heart failure. Twenty-four per cent of 56 patients who underwent the ECG had left ventricular systolic dysfunction and an another 8 had normal systolic function with another ECG diagnosis consistent with a diagnosis of heart failure with preserved systolic function.
Only 5 patients with an echocardiographic diagnosis of heart failure
had normal cardiograms, resulting in a positive predictive value of 0.68 for an abnormal ECG and a negative predictive value of 0.69 for a normal ECG.

The report found BNP level to be a poor discriminator between patients with and without left ventricular systolic dysfunction, the researchers note, even though BNP was significantly higher in patients with echocardiographic features consistent with heart failure.

For more information: www.biomedcentral.com/bmccardiovascdisord/

Related Content

AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG| July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
iRhythm and Stanford Researchers Develop Deep Learning-Based Cardiac Arrhthymia Detection Algorithm
News | Artificial Intelligence| July 11, 2017
iRhythm Technologies Inc. announced a collaboration with the Stanford Machine Learning Group that has resulted in the...
Sponsored Content | Videos | EP Mapping and Imaging Systems| February 01, 2017
This video, provided by Medtronic, demonstrates the CardioInsight electro-anatomical mapping system.
medtronic cardioinsight electromapping system, electoanatomical mapping, noninvasive ep mapping

A screen shot of the waveforms and the the 3-D electo-mapping models created using the noninvasive CardioInsight system.

Technology | EP Mapping and Imaging Systems| February 01, 2017
February 1, 2017 — Medtronic received U.S.
Heart Test Laboratories, HTL, MyoVista ECG, common stock offering
News | ECG| January 31, 2017
Heart Test Laboratories Inc. (HTL) has successfully raised $12 million by way of a Common Stock private placement...
ecg management systems, GE Muse

The latest version of GE’s Muse ECG management system allows integration with other vendors’ ECG, stress testing and Holter monitoring systems.

Feature | ECG Management Systems| January 30, 2017 | Dave Fornell
The movement from paper electrocardiogram (ECG) review to electronic ECG management systems in the past decade has he
ECG, heartbeat, password access, electronic health records, Binghamton University SUNY study, Zhanpeng Jin
News | Electronic Medical Records (EMR)| January 26, 2017
Researchers at Binghamton University, State University of New York have devised a new way to protect personal...
News | Atrial Fibrillation| January 04, 2017
January 4, 2017 — A smartphone application made it possible to use the iPhone camera to detect atrial fibrillation vi
Overlay Init